GLP-1 drugs and pricing rules squeeze dairy farms
Record butter and cheese demand fails to lift profits
15 April 2026
1 minute read
By: US dairy producers are navigating a rapidly shifting landscape as evolving consumer trends and federal milk pricing changes combine to pressure farm-level profitability, even as overall dairy demand remains resilient, according to a press release from Iowa State University.
New market analysis highlight the growing influence of GLP-1 weight-loss medications on food consumption patterns. With an estimated one in eight Americans now using these drugs, and projections reaching 18 million US users by 2029. Dietary habits are shifting toward smaller portions, higher protein intake, and nutrient-dense foods.
For dairy, this trend presents a mixed outlook. Categories such as yogurt, kefir, and cottage cheese are benefiting from increased demand for high-protein, low-fat options. Yogurt consumption alone rose 6 percent year-over-year. However, households using GLP-1 medications are reducing spending on higher-fat dairy products, including butter (-6%), cheese (-7%), and cream (-5%).
Despite this, overall US consumption of high-fat dairy remains strong. In 2024, Americans consumed record levels of butter (6.8 pounds per capita), while cheese held steady at 41.9 pounds, and ice cream rose to 12 pounds per person, underscoring continued consumer appetite.
While increased consumption of dairy components is a good thing, dairy farmers are facing significant financial headwinds tied to recent changes in federal milk pricing formulas. The American Dairy Coalition (ADC) reports that updated “make allowances” within Federal Milk Marketing Orders (FMMOs)—now totalling $3 to $5 per hundredweight—have reduced producer milk check revenue by approximately 5%.
Industry analysis shows processor margins have increased sharply since mid-2025, with Class III margins up 26.7% and Class IV margins up 39.1 percent, while farmers absorb the downside. Meanwhile, the gap between USDA-reported mailbox prices and all-milk prices has widened to $1.00 per cwt, further squeezing producer income.
Compounding the issue, improved milk component levels have increased processing efficiency—reducing the volume of milk needed to produce finished products—yet current pricing formulas amplify negative impacts on producers.
Producer organizations are urging the USDA to ensure transparency through newly mandated audited cost surveys, authorized under the One Big Beautiful Bill Act of 2025, to prevent cost-shifting to producers and restore fairness in pricing formulas. Demand for higher-value, differentiated dairy products remains strong, particularly among higher-income consumers who are more likely to use GLP-1 medications.
However, industry leaders emphasize that without reforms to federal pricing systems, these market opportunities most likely will not translate into improved returns for producers.
